8102
-
Cancer Management and Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Cancer Management and Research
(400,449) Views
Editor in Chief Kenan Onel, MD
1179-1322
ReviewEfficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update
Marvin Omar Delgado-Guay
Cancer Management and Research 2010, 2:303-306
24 November 2010
Review
Cancer chemotherapy: targeting folic acid synthesis
Nicole Hagner, Markus Joerger
Cancer Management and Research 2010, 2:293-301
19 November 2010
Original Research
The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients
Georgios Hillas, Petros Bakakos, Miltiadis Trichas, et al
Cancer Management and Research 2010, 2:287-291
15 November 2010
Review
Review of catumaxomab in the treatment of malignant ascites
Martin Sebastian
Cancer Management and Research 2010, 2:283-286
08 November 2010
Review
The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice
Mette Mogensen, Gregor BE Jemec
Cancer Management and Research 2010, 2:277-282
28 October 2010
Review
FACE: the barefaced facts of AI potency
Alain Monnier
Cancer Management and Research 2010, 2:267-276
27 October 2010
Review
Epigenomics in cancer management
Fabricio F Costa
Cancer Management and Research 2010, 2:255-265
27 October 2010
Review
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
Piotr Milecki, Piotr Martenka, Andrzej Antczak, et al
Cancer Management and Research 2010, 2:243-253
11 October 2010
Review
New developments in treatment of ovarian carcinoma: focus on trabectedin
Philippe A Cassier, Aude Duret, Olivier Trédan, et al
Cancer Management and Research 2010, 2:233-242
01 October 2010
Review
Role of intranasal fentanyl in breakthrough pain management in cancer patients
Wojciech Leppert
Cancer Management and Research 2010, 2:225-232
30 September 2010
Original Research
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al
Cancer Management and Research 2010, 2:219-223
17 September 2010
Case Series
Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients
Henry G Kaplan, Judith A Malmgren, Mary Atwood, et al
Cancer Management and Research 2010, 2:213-218
20 August 2010
Review
Treatment of cutaneous melanoma: current approaches and future prospects
Alain P Algazi, Christopher W Soon, Adil I Daud
Cancer Management and Research 2010, 2:197-211
17 August 2010
Review
Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer
Daiki Ogawara, Minoru Fukuda, Yoichi Nakamura, et al
Cancer Management and Research 2010, 2:191-195
11 August 2010
Review
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
S Galimberti, M Petrini
Cancer Management and Research 2010, 2:181-189
28 June 2010
Review
Ixabepilone development across the breast cancer continuum: a paradigm shift
Nuhad K Ibrahim
Cancer Management and Research 2010, 2:169-179
30 June 2010
Short Report
Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials
Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al
Cancer Management and Research 2010, 2:165-168
28 June 2010
Review
Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review
Matthew S Wiggins, Emily M Simonavice
Cancer Management and Research 2010, 2:157-164
09 June 2010
Review
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Cancer Management and Research 2010, 2:143-156
01 June 2010
Original Research
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults
Paul J Novotny, Denise J Smith, Lorna Guse, et al
Cancer Management and Research 2010, 2:133-142
27 May 2010
Review
Management of metastatic renal cell carcinoma in patients with poor prognosis
Andrea Bullock, David F McDermott, Michael B Atkins
Cancer Management and Research 2010, 2:123-132
24 May 2010
Review
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit
Paul G Corn, Timothy C Thompson
Cancer Management and Research 2010, 2:111-122
10 May 2010
Expert Opinion
Global cancer research initiative
Richard R Love
Cancer Management and Research 2010, 2:105-109
03 May 2010
Review
Role of bevacizumab therapy in the management of glioblastoma
Scott J Peak, Victor A Levin
Cancer Management and Research 2010, 2:97-104
22 April 2010
Review
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab
Ronald M Bukowski
Cancer Management and Research 2010, 2:83-96
26 March 2010
Review
Rituximab for the treatment of patients with chronic lymphocytic leukemia
M Gentile, E Vigna, C Mazzone, et al
Cancer Management and Research 2010, 2:71-81
11 March 2010
Review
Everolimus – a new approach in the treatment of renal cell carcinoma
G Anandappa, AE Hollingdale, TG Eisen
Cancer Management and Research 2010, 2:61-70
09 March 2010
Review
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
Frederick Lansigan, Diane M Stearns, Francine Foss
Cancer Management and Research 2010, 2:53-59
05 February 2010
Review
Evaluation of degarelix in the management of prostate cancer
Hendrik Van Poppel
Cancer Management and Research 2010, 2:39-52
25 January 2010
Review
Optimal management of cancer anorexia–cachexia syndrome
Josep M Argilés, Mireia Olivan, Sílvia Busquets, et al
Cancer Management and Research 2010, 2:27-38
22 January 2010
Review
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
Catherine Oakman, Marta Pestrin, Elena Zafarana, et al
Cancer Management and Research 2010, 2:13-25
07 January 2010
Review
Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
Albert Tuca
Cancer Management and Research 2010, 2:1-12
16 December 2009
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
